[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"home-blood-pressure\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:home-blood-pressure":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":5},"100505252","home-blood-pressure-intervention-in-the-community-trial-100505252",false,"NCT05858944","Home Blood Pressure Intervention in the Community Trial","Inclusion Criteria:\n\n* Aged 60-80 years old\n* Have been taking antihypertensive drugs for more than 2 weeks\n* The average SBP and\u002For DBP of 7-day home blood pressure monitoring ≥135\u002F85 mmHg\n* Willing to participate, adhere to follow-up, and sign the written informed consent form\n\nExclusion Criteria:\n\n* Arm circumference too large or too small (less than 18 cm or greater than 42 cm) to fit the cuff in case of inaccurate measurement\n* Invalid home blood pressure monitoring. The valid home blood pressure monitoring requires consecutive measurements for at least 3 days, with not less than 1 measurement in the morning and evening, respectively.\n* Office blood pressure indicates stage 3 clinic hypertension (≥180\u002F110 mmHg) during the screening period\n* Suspected or known secondary hypertension\n* Orthostatic hypotension, defined as a decrease in systolic blood pressure greater than 20 mmHg or diastolic blood pressure greater than 10 mmHg within 3 minutes when position is changed from sitting to standing\n* eGFR\\\u003C30 ml\u002Fmin\u002F1.73m2 or end-stage renal disease\n* Cardiovascular events occured within the past 3 months, such as myocardial infarction, stroke, acute heart failure, hospitalization for unstable angina, undergoing coronary artery revascularization or bypass grafting\n* Abnormal liver function (ALT\u002FAST\u002Ftotal bilirubin more than 2 times the upper limit of normal value)\n* Severe somatic disease with a life expectancy of less than 3 years, or diagnosed with cancer within the past 2 years requiring treatment\n* Doctors deem that the participation would do harm to the patients or the patients would have poor compliance.","ALL","60 Years","80 Years",{"count":19,"type":20},10000,"ESTIMATED","INTERVENTIONAL",[23],"NA","The primary purpose of the study is to explore whether a lower home blood pressure target (125\u002F75 v.s. 135\u002F85 mmHg) would be beneficial to elderly treated hypertensive patients in terms of reduced incidence of cardiovascular events. The study also aims to promote the application of standardised and information-based home blood pressure monitoring in community hypertension management.",[26],"Home Blood Pressure","RECRUITING","2025-01-02",{"date":30,"type":31},"2025-01-06","ACTUAL",{"date":33,"type":31},"2023-05-06",{"date":35,"type":20},"2030-06-30",{"name":37,"class":38},"Shanghai Institute of Hypertension","OTHER"]